Effect of selenium supplementation on CD4+ T-cell recovery, viral suppression and morbidity of HIV-infected patients in Rwanda: a randomized controlled trial.
[en] OBJECTIVE: To examine the effect of selenium supplementation on CD4 T-cell counts, viral suppression, and time to antiretroviral therapy (ART) initiation in ART-naive HIV-infected patients in Rwanda. METHODS: A multicenter, double-blinded, placebo-controlled, randomized clinical trial was conducted. Eligible patients were HIV-infected adults (>/=21 years) who had a CD4 cell count between 400 and 650 cells/mul (ART eligibility was </=350 cells/mul throughout the trial), and were willing to practice barrier methods of birth control. Patients were randomized to receive once-daily 200 mug selenium tablets or identical placebo. They were followed for 24 months with assessments every 6 months. Declines in CD4 cell counts were modeled using linear regressions with generalized estimating equations and effect modification, and the composite outcome (ART eligible or ART initiation) using Cox proportional-hazards regression, both conducted with intention to treat. RESULTS: Of the 300 participants, 149 received selenium, 202 (67%) were women, and median age was 33.5 years. The rate of CD4 depletion was reduced by 43.8% [95% confidence interval (CI) 7.8-79.8% decrease] in the treatment arm - from mean 3.97 cells/mul per month to mean 2.23 cells/mul per month. We observed 96 composite outcome events - 45 (47%) in the treatment arm. We found no treatment effect for the composite outcome (hazard ratio 1.00, 95% CI 0.66-1.54) or viral suppression (odds ratio 1.18, 95% CI 0.71-1.94). The trial was underpowered for the composite outcome due to a lower-than-anticipated event rate. Adverse events were comparable throughout. CONCLUSIONS: This randomized clinical trial demonstrated that 24-month selenium supplementation significantly reduces the rate of CD4 cell count decline among ART-naive patients.
Effect of selenium supplementation on CD4+ T-cell recovery, viral suppression and morbidity of HIV-infected patients in Rwanda: a randomized controlled trial.
Semba RD, Tang AM. Micronutrients and the pathogenesis of human immunodeficiency virus infection. Br J Nutr 1999; 81:181-189.
Gross RL, Newberne PM. Role of nutrition in immunologic function. Physiol Rev 1980; 60:188-302.
Bendich A. Micronutrients and immune responses. Ann N Y Acad Sci 1990; 587:168-180.
Beisel WR. Single nutrients and immunity. Am J Clin Nutr 1982; 35 (suppl):417-468.
Beisel WR. Vitamins and the immune system. Ann N Y Acad Sci 1990; 587:5-8.
Baum M, Cassetti L, Bonvehi P, Shor-Posner G, Lu Y, Sauberlich H. Inadequate dietary intake and altered nutrition status in early HIV-1 infection. Nutrition 1994; 10:16-20.
Beach RS, Mantero-Atienza E, Shor-Posner G, Javier JJ, Szapocznik J, Morgan R, et al. Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS 1992; 6:701-708.
Baum MK, Shor-Posner G, Zhang G, Lai H, Quesada JA, Campa A, et al. HIV-1 infection in women is associated with severe nutritional deficiencies. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16:272-278.
Abrams B, Duncan D, Hertz-Picciotto I. A prospective study of dietary intake and acquired immune deficiency syndrome in HIV-seropositive homosexual men. J Acquir Immune Defic Syndr 1993; 6:949-958.
Tang AM, Graham NM, Kirby AJ, McCall AD, Willett WC, Saah AJ. Dietary micronutrient intake and risk progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. Am J Epidemiol 1993; 138:1-15.
Ehrenpreis ED, Carlson SJ, Boorstein HL, Craig RM. Malabsorption and deficiency of vitamin B12 in HIV-infected patients with chronic diarrhea. Dig Dis Sci 1994; 39:2159-2162.
Allavena C, Dousset B, May T, Dubois F, Canton P, Belleville F. Relationship of trace element, immunological markers, and HIV1 infection progression. Biol Trace Elem Res 1995; 47.:133- 138.
Baum MK, Shor-Posner G, Lu Y, Rosner B, Sauberlich HE, Fletcher MA, et al. Micronutrients and HIV-1 disease progression. AIDS 1995; 9.:1051-1056.
Tang AM, Graham NM, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection. Am J Epidemiol 1996; 143:1244-1256.
Tang AM, Graham NM, Semba RD, Saah AJ. Association between serum vitamin A and E concentrations and HIV-1 disease progression. AIDS 1997; 11:613-620.
Tang AM, Graham NM, Chandra RK, Saah AJ. Low serum vitamin B-12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. J Nutr 1997; 127:345-351.
Baum MK, Shor-Posner G. Nutritional status and survival in HIV-1 disease. AIDS 1997; 11:689-690.
Baum MK, Shor-Posner G, Lai S, et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15:370-374.
Haug CJ, Aukrust P, Haug E, Morkrid L, Muller F, Froland SS. Severe deficiency of 1, 25-dihydrovitamin D3 in human immunodeficiency virus infection: Association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab 1998; 83:3832-3838.
Campa A, Shor-Posner G, Indacochea F, Zhang G, Lai H, Asthana D, et al. Mortality risk in selenium-deficient HIVpositive children. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20:508-513.
Visser ME, Maartens G, Kossew G, Hussey GD. Plasma vitamin A and zinc concentrations in HIV-infected adults in Cape Town, South Africa. Br J Nutr 2003; 89:475-482.
Olmsted L, Schrauzer G, Flores-Arce M, Dowd J. Selenium supplementation of symptomatic human immunodeficiency virus infected patients. Biol Trace Elem Res 1988; 20:59-65.
Dworkin BM, Rosenthal WS, Wormser GP, Weiss L, Nunez M, Joline C, Herp A. Abnormalities of blood selenium and glutathione peroxidase activity in patients with acquired immunodeficiency syndrome and aids-related complex. Biol Trace Elem Res 1988; 15:167-177.
Lei X, Cheng W, McClung J. Metabolic regulation and function of glutathione peroxidase-1. Ann Rev Nutr 2007; 27:41-61.
Jurkovič S, Osredkar J, Marc J. Molecular impact of glutathione peroxidases in antioxidant processes. Biochem Med 2008; 18:162-174.
Arthur J, McKenzie R, Beckett G. Selenium in the immune system. J Nutr 2003; 133:1457S-1459S.
Beck M. Regulation of cellular immune responses by selenium. Proc Nutr Soc 1999; 58:707-711.
Beck M, Levander O, Handy J. Selenium deficiency and viral infection. J Nutr 2003; 133:1457S-1459S.
Gill H, Walker G. Selenium, immune function and resistance to viral infections. Nutr Diet 2008; 65 (Suppl 3):S41- S47.
Kiremidjian-Schumacher L, Roy M, Wishe H, Cohen M. Regulation of cellular immune responses by selenium. Biol Trace Elem Res 1992; 33:23-35.
Kiremadjian-Schumacher L, Roy M, Wishe HI, Cohen MW, Stotzky G. Supplementation with selenium augments the function of natural killer and lymphokine-Activated killer cells. Biol Trace Elem Res 1996; 52:227-239.
Spallholz JE, Boylan LM, Larsen HS. Advances in understanding selenium's role in the immune system. Ann N Y Acad Sci 1990; 587:123-139.
Harvard School of Public Health News. Costly noncommunicable diseases on rise in developing world. [Online]. Available at: http://www.hsph.harvard.edu/news/hsph-in-The-news/globalhealth-noncommunicable-diseases-bloom/Accessed on: April 6, 2015.
Courtman C, Ryssen Jv, Oelofse A. Selenium concentration of maize grain in South Africa and possible factors influencing the concentration. South Afr J Anim Sci 2012; 42:454- 458.
Hurst R, Siyame E, Young S, Chillimba A, Joy E, Black CR, et al. Soil-Type influences human selenium status and underlies widespread selenium deficiency risks in Malawi. Sci Rep 2012; 3:1-6.
Baum MK, Campa A, Lai S, Sales Martinez S, Tsalaile L, Burns P, et al. Effect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naive, HIV-infected adults in Botswana: A randomized clinical trial. JAMA 2013; 310:2154-2163.
Hurwitz BE, Klaus JR, Llabre MM, Gonzalez A, Lawrence PJ, Maher KJ, et al. Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: A randomized controlled trial. Arch Intern Med 2007; 167:148-154.
Kupka R, Mugusi F, Aboud S, Msamanga GI, Finkelstein JL, Spiegelman D, Fawzi WW. Randomized, double-blind, placebo- controlled trial of selenium supplements among HIV-infected pregnant women in Tanzania: effects on maternal and child outcomes. Am J Clin Nutr 2008; 87:1802-1808.
Ross DA, Cousens S, Wedner SH, Sismanidis C. Does selenium supplementation slow progression of HIV? Potentially misleading presentation of the results of a trial. Arch Intern Med 2007; 167:1555-1556 [author reply 1557].
Lim S, Vos T, Flaxman A, Danaei G, Shibuya K, Adair-Rohani H. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2224-2260.
Hamers R, Kityo C, Lange J, Wit TRd, Mugyenyi P. Global threat from drug resistant HIV in sub-Saharan Africa. BMJ 2012; 344:e4159.
